Efficacy of Anthocyanin from Curly Kale Extract on the Reduction of Oxidative Stress in Patients with Lymphoma After Treated with CHOP or CHOP-like Regimen A Randomized Placebo-Controlled Study

Efficacy of Anthocyanin from Curly Kale Extract on the Reduction of Oxidative Stress in Patients with Lymphoma After Treated with CHOP or CHOP-like Regimen

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230619003

Enrollment

Registered

2023-06-19

Start date

2022-04-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with lymphoma who recently treatment with CHOP or CHOP-like regimens within 60 days Lymphoma Antioxidant Curly kale anthocyanin

Interventions

Curly kale extract containing about 165.6 micrograms per day of anthocyanin,placebo made from identical capsule and packaging , containing with food graded maltodextrin.

Experimental Dietary Supplement,Placebo Comparator No treatment

Anthocyanin arm,Placebo arm

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients age 18 years old and above 2) Diagnosed with lymphoma and recently completed treatment with CHOP or CHOP-liked chemotherapy within 60 days 3) ECOG performance status 0-2

Exclusion criteria

Exclusion criteria: 1) Patients who need to be treated with further chemotherapy within 2 month 2) Patients who are not able to take oral medication 3) History of allergic to Curly Kale 4) Inability or unwillingness to give consent

Design outcomes

Primary

Measure	Time frame
oxidative marker reduction 2 months malondialdehyde (MDA)	—

Secondary

Measure	Time frame
antioxidant increment 2 months superoxide dismutase (SOD)	—

Countries

Thailand

Contacts

Public ContactPongpaisan Saengnak

Chiang Mai University

pungpond678@gmail.com0899398263

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026